{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T02:18:29Z","timestamp":1773368309633,"version":"3.50.1"},"reference-count":55,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Rheumatoid arthritis (RA) is an autoimmune disease marked by the production of autoantibodies (AAb) against citrullinated proteins\/peptides (ACPA). The shared epitope (SE) in the HLA-DRB1 gene is a major genetic risk factor for RA and has been linked to ACPA production, particularly in individuals exposed to environmental triggers such as smoking. However, the role of the SE itself, especially in its citrullinated form, as a target of humoral immunity in RA remains underexplored.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analyzed autoantibodies against SE-containing peptides (SE-AAb) in 150 RA patients, 62 patients with psoriatic arthritis (PsA), and 204 healthy controls. HLA-DRB1 polymorphisms associated with the SE (QKRAA, QRRAA, RRRAA) were evaluated by PCR-SSO. IgG reactivity against native, citrullinated, and carbamylated SE peptides, in linear and cyclic conformations, was assessed using a custom ELISA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>SE-AAb were detected in RA patients with frequencies ranging from 26.0% to 45.3%, depending on peptide conformation and post-translational modification, with the highest positivity observed against citrullinated SE peptides. Antibodies against cyclated citrullinated SE peptides were present in 45.3% of RA patients, compared with 21.6% of healthy controls. PsA patients also showed SE-AAb positivity, with frequencies ranging from 17.7% to 35.5%, displaying a pattern largely similar to RA. No significant association was observed between SE-AAb positivity and SE genetic carriage, and SE-AAb presence was not associated with clinical features of RA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>SE-AAb are present in RA patients, particularly against citrullinated SE peptides, but are not specific to RA, as similar reactivity is observed in PsA. The presence of these autoantibodies is independent of SE genetic carriage, suggesting that inflammatory conditions rather than genetic SE status may contribute to their generation. Further studies are needed to clarify the clinical relevance of SE-AAb in RA pathogenesis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1744370","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T06:47:26Z","timestamp":1772520446000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Presence of autoantibodies targeting the shared epitope in rheumatoid arthritis and psoriatic arthritis"],"prefix":"10.3389","volume":"17","author":[{"given":"Eduard","family":"Graell","sequence":"first","affiliation":[{"name":"Rheumatology Department, Parc Taul\u00ed Hospital Universitari","place":["Sabadell, Spain"]},{"name":"Institut d\u2019Investigaci\u00f3 i Innovaci\u00f3 Parc Taul\u00ed (I3PT-Centres de Recerca de Catalunya (CERCA)), Universitat Aut\u00f2noma de Barcelona","place":["Sabadell, Spain"]},{"name":"Inflammatory Joint Diseases, Bone Metabolism, and Systemic Autoimmune Diseases Research Group, Institut d\u2019Investigaci\u00f3 i Innovaci\u00f3 Parc Taul\u00ed (I3PT-CERCA)","place":["Sabadell, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Francisco","family":"Delgado","sequence":"additional","affiliation":[{"name":"Institut d\u2019Investigaci\u00f3 i Innovaci\u00f3 Parc Taul\u00ed (I3PT-Centres de Recerca de Catalunya (CERCA)), Universitat Aut\u00f2noma de Barcelona","place":["Sabadell, Spain"]},{"name":"Inflammatory Joint Diseases, Bone Metabolism, and Systemic Autoimmune Diseases Research Group, Institut d\u2019Investigaci\u00f3 i Innovaci\u00f3 Parc Taul\u00ed (I3PT-CERCA)","place":["Sabadell, Spain"]},{"name":"Immunology Laboratory, Clinical Laboratories Service, Parc Taul\u00ed Hospital Universitari","place":["Sabadell, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Domingo Gomez","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Parc Taul\u00ed Hospital Universitari","place":["Sabadell, Spain"]},{"name":"Institut d\u2019Investigaci\u00f3 i Innovaci\u00f3 Parc Taul\u00ed (I3PT-Centres de Recerca de Catalunya (CERCA)), Universitat Aut\u00f2noma de Barcelona","place":["Sabadell, Spain"]},{"name":"Inflammatory Joint Diseases, Bone Metabolism, and Systemic Autoimmune Diseases Research Group, Institut d\u2019Investigaci\u00f3 i Innovaci\u00f3 Parc Taul\u00ed (I3PT-CERCA)","place":["Sabadell, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Garc\u00eda-Marique","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Parc Taul\u00ed Hospital Universitari","place":["Sabadell, Spain"]},{"name":"Institut d\u2019Investigaci\u00f3 i Innovaci\u00f3 Parc Taul\u00ed (I3PT-Centres de Recerca de Catalunya (CERCA)), Universitat Aut\u00f2noma de Barcelona","place":["Sabadell, Spain"]},{"name":"Inflammatory Joint Diseases, Bone Metabolism, and Systemic Autoimmune Diseases Research Group, Institut d\u2019Investigaci\u00f3 i Innovaci\u00f3 Parc Taul\u00ed (I3PT-CERCA)","place":["Sabadell, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Menna","family":"Rusi\u00f1ol","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Parc Taul\u00ed Hospital Universitari","place":["Sabadell, Spain"]},{"name":"Institut d\u2019Investigaci\u00f3 i Innovaci\u00f3 Parc Taul\u00ed (I3PT-Centres de Recerca de Catalunya (CERCA)), Universitat Aut\u00f2noma de Barcelona","place":["Sabadell, Spain"]},{"name":"Inflammatory Joint Diseases, Bone Metabolism, and Systemic Autoimmune Diseases Research Group, Institut d\u2019Investigaci\u00f3 i Innovaci\u00f3 Parc Taul\u00ed (I3PT-CERCA)","place":["Sabadell, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Rodrigo","sequence":"additional","affiliation":[{"name":"Inflammatory Joint Diseases, Bone Metabolism, and Systemic Autoimmune Diseases Research Group, Institut d\u2019Investigaci\u00f3 i Innovaci\u00f3 Parc Taul\u00ed (I3PT-CERCA)","place":["Sabadell, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoni","family":"Berenguer-Llergo","sequence":"additional","affiliation":[{"name":"Inflammatory Joint Diseases, Bone Metabolism, and Systemic Autoimmune Diseases Research Group, Institut d\u2019Investigaci\u00f3 i Innovaci\u00f3 Parc Taul\u00ed (I3PT-CERCA)","place":["Sabadell, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordi","family":"Gratacos","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Parc Taul\u00ed Hospital Universitari","place":["Sabadell, Spain"]},{"name":"Institut d\u2019Investigaci\u00f3 i Innovaci\u00f3 Parc Taul\u00ed (I3PT-Centres de Recerca de Catalunya (CERCA)), Universitat Aut\u00f2noma de Barcelona","place":["Sabadell, Spain"]},{"name":"Inflammatory Joint Diseases, Bone Metabolism, and Systemic Autoimmune Diseases Research Group, Institut d\u2019Investigaci\u00f3 i Innovaci\u00f3 Parc Taul\u00ed (I3PT-CERCA)","place":["Sabadell, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan","family":"Calvet","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Parc Taul\u00ed Hospital Universitari","place":["Sabadell, Spain"]},{"name":"Institut d\u2019Investigaci\u00f3 i Innovaci\u00f3 Parc Taul\u00ed (I3PT-Centres de Recerca de Catalunya (CERCA)), Universitat Aut\u00f2noma de Barcelona","place":["Sabadell, Spain"]},{"name":"Inflammatory Joint Diseases, Bone Metabolism, and Systemic Autoimmune Diseases Research Group, Institut d\u2019Investigaci\u00f3 i Innovaci\u00f3 Parc Taul\u00ed (I3PT-CERCA)","place":["Sabadell, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/art.21678","article-title":"Predictors of joint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate with or without concomitant infliximab: Results from the ASPIRE trial","volume":"54","author":"Smolen","year":"2006","journal-title":"Arthritis Rheumatism"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4061\/2011\/815038","article-title":"A systematic review of serum biomarkers anti-cyclic citrullinated peptide and rheumatoid factor as tests for rheumatoid arthritis","volume":"2011","author":"Taylor","year":"2011","journal-title":"Autoimmune Dis"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-020-00816-x","article-title":"The immunology of rheumatoid arthritis","volume":"22","author":"Weyand","year":"2021","journal-title":"Nat Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2019.102392","article-title":"An overview of autoantibodies in rheumatoid arthritis","volume":"110","author":"Van Delft","year":"2020","journal-title":"J Autoimmun"},{"key":"B5","doi-asserted-by":"publisher","first-page":"R135","DOI":"10.1186\/ar2802","article-title":"Diagnostic and prognostic value of antibodies against chimeric fibrin\/filaggrin citrullinated synthetic peptides in rheumatoid arthritis","volume":"11","author":"Sanmart\u00ed","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-021-08890-1","article-title":"Autoantibodies in rheumatoid arthritis: historical background and novel findings","volume":"63","author":"Sokolova","year":"2021","journal-title":"Clin Rev Allerg Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/art.27584","article-title":"Rheumatoid arthritis classification criteria: An American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheumatism"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.076679","article-title":"Duration of preclinical rheumatoid arthritis-related autoantibody positivity increases in subjects with older age at time of disease diagnosis","volume":"67","author":"Majka","year":"2008","journal-title":"Ann Rheumatic Dis"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e35296","DOI":"10.1371\/journal.pone.0035296","article-title":"Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis","volume":"7","author":"Sokolove","year":"2012","journal-title":"PloS One"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/art.11223","article-title":"Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis","volume":"48","author":"Rantap\u00e4\u00e4-Dahlqvist","year":"2003","journal-title":"Arthritis Rheumatism"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/art.22279","article-title":"Isotype distribution of ANTI\u2013CYCLIC citrullinated peptide antibodies in undifferentiated arthritis and rheumatoid arthritis reflects an ongoing immune response","volume":"54","author":"Verpoort","year":"2006","journal-title":"Arthritis Rheumatism"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/art.24385","article-title":"Quantitative heritability of anti\u2013citrullinated protein antibody\u2013positive and anti\u2013citrullinated protein antibody\u2013negative rheumatoid arthritis","volume":"60","author":"Van Der Woude","year":"2009","journal-title":"Arthritis Rheumatism"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/art.20553","article-title":"A gene\u2013environment interaction between smoking and shared epitope genes in HLA\u2013DR provides a high risk of seropositive rheumatoid arthritis","volume":"50","author":"Padyukov","year":"2004","journal-title":"Arthritis Rheumatism"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s00393-017-0328-y","article-title":"Association between anti-Porphyromonas gingivalis antibody, anti-citrullinated protein antibodies, and rheumatoid arthritis: A meta-analysis","volume":"77","author":"Bae","year":"2018","journal-title":"Z Rheumatol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.162.1.585","article-title":"The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues","volume":"162","author":"Girbal-Neuhauser","year":"1999","journal-title":"J Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2005.044743","article-title":"Citrullinated fibrinogen detected as a soluble citrullinated autoantigen in rheumatoid arthritis synovial fluids","volume":"65","author":"Takizawa","year":"2006","journal-title":"Ann Rheumatic Dis"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.6.4177","article-title":"The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the \u03b1- and \u03b2-chains of fibrin","volume":"166","author":"Masson-Bessi\u00e8re","year":"2001","journal-title":"J Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1258\/acb.2007.007205","article-title":"Detection of citrullinated proteins in synovial fluids derived from patients with rheumatoid arthritis by proteomics-based analysis","volume":"45","author":"Tabushi","year":"2008","journal-title":"Ann Clin Biochem"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200535790","article-title":"Epitopes of human fibrin recognized by the rheumatoid arthritis-specific autoantibodies to citrullinated proteins","volume":"36","author":"Sebbag","year":"2006","journal-title":"Eur J Immunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e0165501","DOI":"10.1371\/journal.pone.0165501","article-title":"Characterization of autoantigens targeted by anti-citrullinated protein antibodies in vivo: prominent role for epitopes derived from histone 4 proteins","volume":"11","author":"Meng","year":"2016","journal-title":"PloS One"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/art.23936","article-title":"Antibodies to citrullinated \u03b1-enolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolase","volume":"58","author":"Lundberg","year":"2008","journal-title":"Arthritis Rheumatism"},{"key":"B22","doi-asserted-by":"publisher","first-page":"R38","DOI":"10.1186\/ar2644","article-title":"Candidate autoantigens identified by mass spectrometry in early rheumatoid arthritis are chaperones and citrullinated glycolytic enzymes","volume":"11","author":"Go\u00ebb","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"B23","doi-asserted-by":"publisher","first-page":"R1421","DOI":"10.1186\/ar1845","article-title":"Identification of citrullinated \u03b1-enolase as a candidate autoantigen in rheumatoid arthritis","volume":"7","author":"Kinloch","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"B24","doi-asserted-by":"publisher","first-page":"R142","DOI":"10.1186\/ar1149","article-title":"Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin","volume":"6","author":"Vossenaar","year":"2004","journal-title":"Arthritis Res Ther"},{"key":"B25","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1093\/rheumatology\/ken077","article-title":"Synovial detection and autoantibody reactivity of processed citrullinated isoforms of vimentin in inflammatory arthritides","volume":"47","author":"Tilleman","year":"2008","journal-title":"Rheumatology"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200526000","article-title":"Humoral immune response to citrullinated collagen type II determinants in early rheumatoid arthritis","volume":"35","author":"Burkhardt","year":"2005","journal-title":"Eur J Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2005.05.137","article-title":"Anti-citrullinated collagen type I antibody is a target of autoimmunity in rheumatoid arthritis","volume":"333","author":"Suzuki","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208495","article-title":"Identification of an immunodominant peptide from citrullinated tenascin-C as a major target for autoantibodies in rheumatoid arthritis","volume":"75","author":"Schwenzer","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"B29","doi-asserted-by":"publisher","first-page":"R175","DOI":"10.1186\/ar2085","article-title":"Identification of novel citrullinated autoantigens of synovium in rheumatoid arthritis using a proteomic approach","volume":"8","author":"Matsuo","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2011.151712","article-title":"Peptidylarginine deiminase 2, 3 and 4 have distinct specificities against cellular substrates: novel insights into autoantigen selection in rheumatoid arthritis","volume":"71","author":"Darrah","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"B31","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.bbrc.2005.12.160","article-title":"Identification of citrullinated eukaryotic translation initiation factor 4G1 as novel autoantigen in rheumatoid arthritis","volume":"341","author":"Okazaki","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1002\/art.37881","article-title":"Identification of citrullinated hsp90 isoforms as novel autoantigens in rheumatoid arthritis\u2013associated interstitial lung disease","volume":"65","author":"Harlow","year":"2013","journal-title":"Arthritis Rheumatism"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.plabm.2024.e00420","article-title":"A comparison of anti-cyclic citrullinated peptides (CCP3 and CCP3.1) autoantibody tests in rheumatoid arthritis","volume":"41","author":"Nelson","year":"2024","journal-title":"Pract Lab Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2019.102400","article-title":"The etiology of rheumatoid arthritis","volume":"110","author":"Scherer","year":"2020","journal-title":"J\u00a0Autoimmun"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1053\/sarh.2002.32552","article-title":"Influence of human leukocyte antigen-DRB1 on the susceptibility and severity of rheumatoid arthritis","volume":"31","author":"Gonzalez-Gay","year":"2002","journal-title":"Semin Arthritis Rheumatism"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26010034","article-title":"The role of vimentin peptide citrullination in the structure and dynamics of HLA-DRB1 rheumatoid arthritis risk-associated alleles","volume":"26","author":"Alves","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA117.001013","article-title":"The interplay between citrullination and HLA-DRB1 polymorphism in shaping peptide binding hierarchies in rheumatoid arthritis","volume":"293","author":"Ting","year":"2018","journal-title":"J Biol Chem"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.2174\/1389450116666150202160954","article-title":"Protein arginine deiminases and associated citrullination: physiological functions and diseases associated with dysregulation","volume":"16","author":"Witalison","year":"2015","journal-title":"CDT"},{"key":"B39","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s00251-017-0987-5","article-title":"HLA class II and rheumatoid arthritis: the bumpy road of revelation","volume":"69","author":"Kampstra","year":"2017","journal-title":"Immunogenetics"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1007\/s00251-007-0224-8","article-title":"The spectrum of HLA-DQ and HLA-DR alleles, 2006: a listing correlating sequence and structure with function","volume":"59","author":"Bondinas","year":"2007","journal-title":"Immunogenetics"},{"key":"B41","doi-asserted-by":"publisher","first-page":"e0144707","DOI":"10.1371\/journal.pone.0144707","article-title":"Contribution of peptide backbone to anti-citrullinated peptide antibody reactivity","volume":"10","author":"Trier","year":"2015","journal-title":"PloS One"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20131241","article-title":"A molecular basis for the association of the HLA-DRB1 locus, citrullination, and rheumatoid arthritis","volume":"210","author":"Scally","year":"2013","journal-title":"J\u00a0Exp Med"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/nm0396-306","article-title":"HLA-DR4 and HLA-DR10 motifs that carry susceptibility to rheumatoid arthritis bind 70-kD heat shock proteins","volume":"2","author":"Auger","year":"1996","journal-title":"Nat Med"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.24.2.227","article-title":"Influence of the QKRAA\/QRRAA\/RRRAA motifs of the third hypervariable region of HLA-DRB1 in the development of rheumatoid arthritis","volume":"24","author":"Auger","year":"1997","journal-title":"J Rheumatol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119348","article-title":"A function for the QKRAA amino acid motif: mediating binding of DnaJ to DnaK. Implications for the association of rheumatoid arthritis with HLA-DR4","volume":"99","author":"Auger","year":"1997","journal-title":"J Clin Invest"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119577","article-title":"Genetic bias in immune responses to a cassette shared by different microorganisms in patients with rheumatoid arthritis","volume":"100","author":"La Cava","year":"1997","journal-title":"J Clin Invest"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.67.6.2769-2775.1999","article-title":"Cross-reactivity between the rheumatoid arthritis-associated motif EQKRAA and structurally related sequences found in Proteus mirabilis","volume":"67","author":"Tiwana","year":"1999","journal-title":"Infect Immun"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1267091","article-title":"The role of inflammation in autoimmune disease: a therapeutic target","volume":"14","author":"Xiang","year":"2023","journal-title":"Front Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/ar2580","article-title":"Psoriatic arthritis: from pathogenesis to therapy","volume":"11","author":"FitzGerald","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-206701","article-title":"Ultrasonographic wrist and hand abnormalities in early psoriatic arthritis patients: correlation with clinical, dermatological, serological and genetic indices","volume":"33","author":"Bandinelli","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1002\/art.21972","article-title":"Classification criteria for psoriatic arthritis: Development of new criteria from a large international study","volume":"54","author":"Taylor","year":"2006","journal-title":"Arthritis Rheumatism"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2015.08.003","article-title":"Auto-reactions, autoimmunity and psoriatic arthritis","volume":"14","author":"Chimenti","year":"2015","journal-title":"Autoimmun Rev"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.062042","article-title":"Ectopic lymphoid neogenesis in psoriatic arthritis","volume":"66","author":"Canete","year":"2007","journal-title":"Ann Rheumatic Dis"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1093\/jalm\/jfab120","article-title":"Autoantibodies in psoriatic disease","volume":"7","author":"Koussiouris","year":"2022","journal-title":"J Appl Lab Med"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/ng.1076","article-title":"Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis","volume":"44","author":"Raychaudhuri","year":"2012","journal-title":"Nat Genet"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1744370\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T14:34:19Z","timestamp":1773326059000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1744370\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,3]]},"references-count":55,"alternative-id":["10.3389\/fimmu.2026.1744370"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1744370","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,3]]},"article-number":"1744370"}}